Furthermore, ZEB1 downregulation through HDAC class I inhibition or DNA demethylation resensitizes pancreatic cancer and osteosarcoma cells to chemotherapy (Meidhof et al, 2015; Ruh et al, 2021). Here, ZEB1 is linked to familial pancreatic carcinoma.